| Multiplex genome engineering using CRISPR/Cas systems L Cong, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, ... Science 339 (6121), 819-823, 2013 | 17906 | 2013 |
| Highly efficient Cas9-mediated transcriptional programming A Chavez, J Scheiman, S Vora, BW Pruitt, M Tuttle, E PR Iyer, S Lin, ... Nature methods 12 (4), 326-328, 2015 | 1554 | 2015 |
| Acute and long-term suppression of feeding behavior by POMC neurons in the brainstem and hypothalamus, respectively C Zhan, J Zhou, Q Feng, J Zhang, S Lin, J Bao, P Wu, M Luo Journal of Neuroscience 33 (8), 3624-3632, 2013 | 472 | 2013 |
| Optimized gene editing technology for Drosophila melanogaster using germ line-specific Cas9 X Ren, J Sun, BE Housden, Y Hu, C Roesel, S Lin, LP Liu, Z Yang, D Mao, ... Proceedings of the National Academy of Sciences 110 (47), 19012-19017, 2013 | 421 | 2013 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ... US Patent App. 14/105,035, 2014 | 272 | 2014 |
| In Vivo Transcriptional Activation Using CRISPR/Cas9 in Drosophila S Lin, B Ewen-Campen, X Ni, BE Housden, N Perrimon Genetics 201 (2), 433-442, 2015 | 135 | 2015 |
| Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi BE Housden, AJ Valvezan, C Kelley, R Sopko, Y Hu, C Roesel, S Lin, ... Science signaling 8 (393), rs9-rs9, 2015 | 126 | 2015 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ... US Patent App. 15/230,161, 2018 | 60 | 2018 |
| Cas9-based genome editing in Drosophila BE Housden, S Lin, N Perrimon Methods in enzymology 546, 415-439, 2014 | 40 | 2014 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ... US Patent App. 16/445,156, 2020 | 27 | 2020 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ... US Patent App. 16/445,150, 2020 | 26 | 2020 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ... US Patent App. 15/967,510, 2019 | 26 | 2019 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ... US Patent App. 15/967,495, 2019 | 26 | 2019 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ... US Patent App. 16/535,043, 2020 | 24 | 2020 |
| Crispr-cas component systems, methods and compositions for sequence manipulation F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ... US Patent App. 16/532,442, 2020 | 24 | 2020 |
| Methods and compositions for genome editing AR Watson, C Foster, LIN Shuailiang US Patent App. 18/148,964, 2023 | | 2023 |
| Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents AR Watson, S Chizari, R Spencer, C Foster, LIN Shuailiang, SM Peyrot, ... US Patent App. 17/453,336, 2023 | | 2023 |
| Sistemas de componente crispr-cas, métodos e composições para manipulação de sequência F Zhang, DO Bikard, L Cong, DBT Cox, P Hsu, W Jiang, LIN Shuailiang, ... | | 2022 |
| Methods and compositions for genome editing AR Watson, C Foster, LIN Shuailiang, SM Peyrot US Patent App. 16/387,507, 2020 | | 2020 |
| Methods and compositions for genome editing AR Watson, C Foster, LIN Shuailiang US Patent App. 16/393,886, 2020 | | 2020 |
